miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis.
Condrat CE, Thompson DC, Barbu MG, Bugnar OL, Boboc A, Cretoiu D, Suciu N, Cretoiu SM, Voinea SC. · 2020
Read miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis. by Condrat CE, Thompson DC, Barbu MG, Bugnar OL, Boboc A, Cretoiu D, Suciu N, Cretoiu SM, Voinea SC. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7072450.txt.
Introduction
Condrat and co-authors review microRNAs as disease biomarkers in the journal Cells. MicroRNAs are small non-coding RNAs that fine-tune protein production by marking messenger RNAs for destruction. Progress in tracing their origins and jobs has raised a practical hope: measuring them could diagnose disease and forecast its course. The authors analysed the literature across major medical databases to judge that hope.
The evidence is promising. MicroRNAs meet most tests of an ideal biomarker: they are accessible in body fluids, and they show high specificity and sensitivity for particular conditions. Standard protocols for using them in the clinic do not yet exist, which is the main limitation. As techniques improve, the authors expect microRNA profiles to become routine, sharpening each patient's personal profile and guiding more specific treatment. The review covers both diagnosis and prognosis, and where the molecules stand for conditions from cancer to heart disease.
Catalog record
| CREATOR | Condrat CE, Thompson DC, Barbu MG, Bugnar OL, Boboc A, Cretoiu D, Suciu N, Cretoiu SM, Voinea SC. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 125 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |